PRESS STATEMENTS02.25.2021 Pfizer Statement on Results of Second Annual Pay Equity Study Among Colleagues Worldwide02.19.2021 President Biden Visits Pfizer’s Kalamazoo Manufacturing Facility02.17.2021 In Vitro Study Published in The New England Journal of Medicine Demonstrates Sera from Individuals Immunized with the Pfizer- BioNTech COVID-19 Vaccine Neutralize SARS-CoV-2 with South African Variant Spike Mutations02.08.2021 Pfizer and BioNTech Publish Data from in Vitro Studies in "Nature Medicine" Demonstrating COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with Key Mutations Present in U.K. and South African Variants02.01.2021 Pfizer and BioNTech Publish Preclinical Data from Investigational COVID-19 Vaccine Program in Nature01.29.2021 Pfizer and BioNTech Publish Data on COVID-19 Vaccine-Induced Antibodies’ Ability to Neutralize SARS-CoV-2 U.K. Strain Pseudovirus in Cell Culture in Science01.27.2021 In Vitro Studies Demonstrate Pfizer and BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with Key Mutations Present in U.K. and South African Variants01.26.2021 Statement on ATMI Ranking01.20.2021 Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture01.15.2021 Statement by Pfizer Chairman and CEO Albert Bourla01.15.2021 Statement on European Upscaling as well as Impact on Deliveries01.08.2021 An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation Associated with Rapid Transmission12.17.2020 Pfizer Update on COVID-19 Vaccine Distribution12.15.2020 Pfizer Doses First Participants as Part of Global Achondroplasia Phase 2 Development Program12.09.2020 Statement on EMA Cyberattack12.01.2020 Pfizer and BioNTech Submitted Application for Conditional Marketing Authorization for COVID-19 Vaccine to the EMA11.20.2020 Pfizer Receives European Approval for Oncology Supportive Care Biosimilar, NYVEPRIA™ (pegfilgrastim)11.16.2020 Pfizer Update On Our U.S. COVID-19 Vaccine Candidate Distribution Preparedness11.10.2020 Pfizer Statement on Geodon (ziprasidone) Trial Closure in the United States10.29.2020 New Report Identifies Need for More Effective Policy Responses and Investment to Prevent Strokes in EuropePagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7Next pageNext ›Last pageLast »Press Release ArchivePress StatementsPodcastsThe Antigen PodcastThe Antigen Podcast Season 1The Antigen Podcast Episode 1: Vaccines 101The Antigen Podcast Episode 2: The History of VaccinesThe Antigen Podcast Episode 3: Global Perspectives, Barriers & SolutionsThe Antigen Podcast Episode 4: Vaccine Hesitancy Part 1The Antigen Podcast Episode 5: Vaccine Hesitancy Part 2The Antigen Podcast Episode 6: Vaccine Politics, Policy & AdvocacyThe Antigen Podcast Episode 7: Innovations in the Vaccine LandscapeThe Antigen Podcast Episode 8: What's Next?The Antigen Podcast Season 2The Antigen Podcast Episode 1: #COVID19 Looking Back to Look ForwardThe Antigen Podcast Episode 2: #COVID19 What Do We Do in the Meantime?The Antigen Podcast Episode 3: #COVID19 The Quest for a VaccineThe Antigen Podcast Episode 4: #COVID19 Teamwork Makes the Dream WorkGet Science PodcastDiverse Perspectives Podcastmenopause: unmutedHemcastContact Media RelationsPress Kits & DownloadsCompany Press KitPfizer Oncology Press KitPSA NarrativeRA NarRAtiveRare Disease Gene Therapy Press KitATTR-Amyloidosis Press KitUC NarrativeEczema Inside Out Press KitOnline Pfizer Press KitCompany Press KitView the Pfizer Company Press KitPress StatementsView Pfizer's latest press statements Related ArticlesYour HealthPfizer's New C. difficile Awareness Initiative ExplainedOur PurposeSome older people living with cancer aim for remission but lack…Our ProductsAlbert Bourla On Ensuring Equitable Access to COVID-19 VaccinesOur PurposeImproving Access to Cures Through InnovationYour HealthLet’s Talk Osteoarthritis Pain: A Picture of Daily LifeOur ScienceThe Facts About Pfizer and BioNTech’s COVID-19 VaccineOur PeopleAn Early Passion for Science and Public Health Inspires Adriana’…Our PeopleSandy Focuses on Diversity in Our Clinical TrialsOur People“The Ice Man” - The Pfizer Colleague & Dad Who Keeps Our…Our ProductsDistributing Our COVID-19 Vaccine to the WorldOur PurposeThe Value of Vaccines in Disease Prevention: A Global PerspectiveOur PurposeThe Value of Vaccines in Disease Prevention in Latin AmericaYour HealthViral vs. Bacterial Pneumonia: Understanding the DifferenceOur ScienceNew Discoveries in Metastatic Breast Cancer Can’t Wait: How…Our PurposeAdvancing Health Equity & Social Justice Through Community…Your HealthIn Her Words: Jacklyn’s Life With Ulcerative ColitisYour HealthEczema and Stress: What's the Link?Your HealthFeeling Sick? Use this Symptom Checker for Common Fall and…Our ScienceAlbert Bourla Discusses Our FDA SubmissionOur ScienceOur COVID-19 Vaccine Study – What’s Next?Your HealthCOVID-19 Vaccine U.S. Distribution Fact SheetShowHide